USPTO Patent Application: Solid Dosage Form of Antiviral Nucleoside
Summary
The USPTO has published a new patent application from Merck Sharp & Dohme LLC for an oral dosage form of a small molecule antiviral nucleoside. The application details specific formulation components and pellet size requirements for the antiviral drug.
What changed
This document is a USPTO patent application (US20260083767A1) filed by Merck Sharp & Dohme LLC. It describes a solid oral dosage form for an antiviral nucleoside, specifying the inclusion of compression aids, glidants, lubricants, and disintegrants. A key feature is that the oral dosage form is a pellet with a diameter of 4.0 mm or less.
This is a patent application, not a regulatory rule or guidance. It does not impose any immediate compliance obligations on pharmaceutical companies. However, it represents a potential future intellectual property asset for Merck Sharp & Dohme LLC related to antiviral drug formulations. Companies involved in antiviral drug development should be aware of this filing as it may impact future market exclusivity or licensing opportunities.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SOLID DOSAGE FORM OF A SMALL MOLECULE ANTIVIRAL AND USES THEREOF
Application US20260083767A1 Kind: A1 Mar 26, 2026
Assignee
Merck Sharp & Dohme LLC
Inventors
Nicole Devitt, Brandon G. Gerberich, Prapti Kafle, Michael Lowinger, Grace A. Okoh, Sanjaykumar Patel, Somya Singh, James S. Tarabokija, Yuejie Zhao
Abstract
The present disclosure relates to oral dosage forms of pharmaceutical formulations that comprise an antiviral nucleoside, one or more compression aids, one or more glidants, and one or more lubricants, and one or more disintegrants, wherein the oral dosage form is a pellet having a diameter of less than or equal to 4.0 mm.
CPC Classifications
A61K 31/7068 A61K 9/16 A61K 9/1611 A61K 9/1617 A61K 9/1652 A61K 9/4808 A61K 9/4816 A61K 9/4858 A61K 9/4866
Filing Date
2023-12-11
Application No.
19137855
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.